Biondo Focus Fund Investor Class (BFONX)

16.80
Net Asset Value
+0.24%
1 Day
+3.83%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
2.66%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in a combination of long and short positions in (1) common stock of U.S. companies of any capitalization; (2) American depositary receipts ("ADRs") representing common stock of foreign companies; (3) investment grade fixed income securities; (4) exchange-traded funds and (5) options on common stock, ADRs and ETFs. It may also employ leverage including bank borrowing of up to 33% of the fund's assets (defined as net assets plus borrowing for investment purposes). The fund is non-diversified.

Performance

1 month+2.56% 3 years+25.45%
3 months-1.35% 5 years+13.35%
1 year+17.73% Since inception+9.10%
Data through --

Peer Comparisonvs. Large growth

 BFONXCategory
Performance 5-yr return+13.35%+13.86%
Expense ratio2.66%1.21%
Risk 5 year sharpe ratio0.500.96
Net assets$29.4M$2.7B
Average market cap$30.0B$76.2B
Average P/E27.022.0
Portfolio turnover52%52%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyBiondo Investment Advisor
Fund manager & tenureJoseph Biondo, Sr. / 5 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock99.56%
Cash0.44%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 32.03%
Financial service 21.84%
Hardware 16.61%
Consumer goods 15.35%
Industrial materials 7.19%
Top 10 Holdings
Portfolio weighting
-- 11.74%
PCRX Pacira Pharmaceuticals Inc11.49%
ILMN Illumina Inc9.61%
CELG Celgene9.32%
CMRX Chimerix Inc6.34%
GILD Gilead Sciences5.55%
MA MasterCard5.31%
F Ford5.22%
FB Facebook5.18%
AAPL Apple5.03%

To view my watchlist

Not a member yet?

Sign up now for a free account